Optimal cancer drug dosing in adolescents: new issues and the old unaddressed ones

Intern Med J. 2018 Sep;48(9):1023-1027. doi: 10.1111/imj.14020.

Authors

Jessica Ryan¹, Joanne Patel, Catherine J Lucas, Jennifer H Martin

Affiliation

¹ Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Level 3 Hunter Medical Research Institute, and Hunter New England Local Health District, Kookaburra Circuit, Newcastle, New South Wales, Australia.

PMID: 30182398
DOI: 10.1111/imj.14020

No abstract available

Publication types

Editorial

MeSH terms

Adolescent
Antineoplastic Agents / pharmacokinetics
Antineoplastic Agents / pharmacology*
Dose-Response Relationship, Drug
Health Risk Behaviors
Humans
Mental Health
Neoplasms / drug therapy*
Obesity / complications
Young Adult

Substances

Antineoplastic Agents